NASDAQ: COOCooper Companies Inc Stock
$90.04-0.38 (-0.42%)
Updated Apr 22, 2024
COO Price
$90.04
Fair Value Price
$38.46
Market Cap
$17.90B
52 Week Low
$75.94
52 Week High
$104.07
P/E
61.46x
P/B
2.33x
P/S
5.05x
PEG
0.89x
Dividend Yield
0.01%
Revenue
$3.67B
Earnings
$290.80M
Gross Margin
66.1%
Operating Margin
14.18%
Profit Margin
7.9%
Debt to Equity
0.56
Operating Cash Flow
$564M
Beta
0.91
Next Earnings
May 30, 2024
Ex-Dividend
N/A
Next Dividend
N/A
COO Overview
Cooper Companies, Inc.'s CooperVision segment manufactures contact lens wearers. Its other segment, CooperSurgical, manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD. Cooper was founded in 1958 and is headquartered in San Ramon, CA.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how COO scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
COO ($90.04) is overvalued by 134.14% relative to our estimate of its Fair Value price of $38.46 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
COO ($90.04) is not significantly undervalued (134.14%) relative to our estimate of its Fair Value price of $38.46 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
COO ($90.04) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more COO due diligence checks available for Premium users.
Be the first to know about important COO news, forecast changes, insider trades & much more!
COO News
Valuation
COO fair value
Fair Value of COO stock based on Discounted Cash Flow (DCF)
Price
$90.04
Fair Value
$38.46
Overvalued by
134.14%
COO ($90.04) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
COO ($90.04) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
COO ($90.04) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
COO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
61.46x
Industry
47.33x
Market
41x
COO is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
COO is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
COO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.33x
Industry
3.48x
COO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
COO price to earnings growth (PEG)
For valuing profitable companies with growth potential
COO is good value based... subscribe to Premium to read more.
PEG Value Valuation
COO's financial health
Profit margin
Revenue
$931.6M
Net Income
$81.2M
Profit Margin
8.7%
COO's Earnings (EBIT) of $519.90M... subscribe to Premium to read more.
Interest Coverage Financials
COO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.0B
Liabilities
$4.3B
Debt to equity
0.56
COO's short-term assets ($1.79B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
COO's long-term liabilities ($3.37B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
COO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
COO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$122.7M
Investing
-$324.1M
Financing
$212.3M
COO's operating cash flow ($563.60M)... subscribe to Premium to read more.
Debt Coverage Financials
COO vs Medical Stocks
Cooper Companies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.